SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
The Neuroscientist
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (72)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Deleo, J. A.
Right arrow Articles by Tawfik, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deleo, J. A.
Right arrow Articles by Tawfik, V. L.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Pain
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia

Joyce A. Deleo

Department of Anesthesiology and Department of Pharmacology & Toxicology, Dartmouth–Hitchcock Medical Center, Lebanon, NH.Joyce.A.DeLeo{at}Dartmouth.edu

Flobert Y. Tanga

Vivianne L. Tawfik

Department of Anesthesiology and Department of Pharmacology & Toxicology, Dartmouth–Hitchcock Medical Center, Lebanon, NH.

One area that has emerged as a promising therapeutic target for the treatment and prevention of chronic pain and opioid tolerance/hyperalgesia is the modulation of the central nervous system (CNS) immunological response that ensues following injury or opioid administration. Broadly defined, central neuroimmune activation involves the activation of cells that interface with the peripheral nervous system and blood. Activation of these cells, as well as parenchymal microglia and astrocytes by injury, opioids, and other stressors, leads to subsequent production of cytokines, cellular adhesion molecules, chemokines, and the expression of surface antigens that enhance a CNS immune cascade. This response can lead to the production of numerous pain mediators that can sensitize and lower the threshold of neuronal firing: the pathologic correlate to central sensitization and chronic pain states. CNS innate immunity and Toll-like receptors, in particular, may be vital players in this orchestrated immune response and may hold the answers to what initiates this complex cascade. The challenge remains in the careful perturbation of injury/opioid-induced neuroimmune activation to down-regulate this process without inhibiting beneficial CNS autoimmunity that subserves neuronal protection following injury.

Key Words: Astrocyte • Chemokines • Cytokines • Glia • MHC II • Microglia • Neuropathic pain • Toll-like receptor 4

The Neuroscientist, Vol. 10, No. 1, 40-52 (2004)
DOI: 10.1177/1073858403259950


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Dou, C. B. Grotepas, J. M. McMillan, C. J. Destache, M. Chaubal, J. Werling, J. Kipp, B. Rabinow, and H. E. Gendelman
Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS
J. Immunol., July 1, 2009; 183(1): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
F. Wei, W. Guo, S. Zou, K. Ren, and R. Dubner
Supraspinal Glial-Neuronal Interactions Contribute to Descending Pain Facilitation
J. Neurosci., October 15, 2008; 28(42): 10482 - 10495.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. S. Griffin, M. Costigan, G. J. Brenner, C. Him Eddie Ma, J. Scholz, A. Moss, A. J. Allchorne, G. L. Stahl, and C. J. Woolf
Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity
J. Neurosci., August 8, 2007; 27(32): 8699 - 8708.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. J. Xu, B. C. Walla, M. F. Diaz, G. N. Fuller, and H. B. Gutstein
Intermittent lumbar puncture in rats: a novel method for the experimental study of opioid tolerance.
Anesth. Analg., September 1, 2006; 103(3): 714 - 720.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy
PNAS, April 19, 2005; 102(16): 5856 - 5861.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal., September 28, 2004; 2004(252): re14 - re14.
[Abstract] [Full Text] [PDF]



Advertisement